title: Icrucumab
text: # Icrucumab
  
  Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors.
  
  Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials.
  
  